Main business: the United States, Canada, Germany, Britain, France, the Netherlands, Romania, Thailand, Japan, South Korea, Indonesia, Malaysia, the Philippines, Kuwait, Brazil, Peru, Hong Kong, etc.
Main business: global High-tech pharmaceutical raw materials, high complex new type intermediates, fine chemicals custom synthesis, scale-up production and Rare chemicals trade.
Switch Channel